LUCILLE TUSSEY: Open Payments
NPI 1326514316 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 38 payments from 9 companies in 2025. Trend: 2023 $372 · 2024 $423 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 12 | $165 |
| Novo Nordisk Inc | 7 | $141 |
| ABBVIE INC. | 5 | $107 |
| PFIZER INC. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| Lilly USA, LLC | 3 | $57 |
| Amgen Inc. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: ZORYVE, Ozempic, AIRSUPRA, PREVNAR 20, QULIPTA, UBRELVY, Wegovy, KRYSTEXXA.
Industry payments across NC — which companies pay providers there.
